Acute kidney injury during vancomycin therapy in critically ill children. - Wikidata - awgldk - TriplyDB

Acute kidney injury during vancomycin therapy in critically ill children.

Acute kidney injury during vancomycin therapy in critically ill children.

http://www.wikidata.org/entity/Q46698824

about

Review of vancomycin-induced renal toxicity: an update Vancomycin monitoring in children using bayesian estimation.Population-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal Insufficiency Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome Factors associated with acute kidney injury in children receiving vancomycin.Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients.Drug Class Combination-Associated Acute Kidney Injury.Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?Frequency of and Risk Factors for Acute Kidney Injury Associated With Vancomycin Use in the Pediatric Intensive Care Unit.Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.Drugs as risk factors of acute kidney injury in critically ill children.Elevated Vancomycin Trough Concentration: Increased Efficacy and/or Toxicity?Increased Vancomycin Exposure and Nephrotoxicity in Children: Therapeutic Does Not Mean Safe MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.Drug-associated acute kidney injury: who's at risk?

P2860

Q26746932-DF798D6F-8C7A-4CD0-BD8F-67D468051CE2 Q33911485-D9A354C9-EA72-4C28-BC77-107524A11467 Q34314798-944E0A9A-1A2E-4DD4-BE43-C8B12D4E31B9 Q36077880-A67C06D9-BDC6-44CB-B58C-0C732D511932 Q36377410-6FAA5100-E061-48F8-9ADC-CCED3228948B Q36576652-1D559AB3-D69A-4B81-82E3-9E553A64F3C1 Q38245931-3150E279-0D95-463D-96F9-702A0A1D78C5 Q38784479-21DF5D80-53D5-497F-A03E-209F5B5A654A Q38889504-1835144F-6155-4AC6-ACFB-909DD44AC8A8 Q39044128-06EC156C-FBBE-4B30-A00E-A799CC6D3BB4 Q39054927-96AC80F8-34D7-410F-A885-809779E6CFF3 Q40483780-F573FAD7-C519-470F-A5C8-C9BB140F2BA2 Q41115090-6896F7B9-5530-45A7-8F45-3D30259F8BFD Q41255520-855BFD23-1FE5-4351-B5F0-54D35D472F2F Q41496143-36335AA5-B3E7-4F1A-AFAB-633EDF72F3C6 Q41545799-B8F63F47-4A12-4BA8-84B3-14E773354FDF Q42580002-C57E6833-7F45-48D1-918C-D3146C2F70ED Q47164367-9A5A4939-CBFD-4A8A-AB89-F6144E70C35B Q48234771-F6038BA2-61D9-4180-BD7A-495EAD7021B5 Q53636658-90908295-E00B-4B0E-8422-56836393E6DE Q53946600-E1A9E6CA-586C-4F83-AF78-17750650E569

P2860

Acute kidney injury during vancomycin therapy in critically ill children.

http://www.wikidata.org/entity/Q46698824

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Acute kidney injury during vancomycin therapy in critically ill children.

@en

Acute kidney injury during vancomycin therapy in critically ill children.

@nl

type

label

Acute kidney injury during vancomycin therapy in critically ill children.

@en

Acute kidney injury during vancomycin therapy in critically ill children.

@nl

prefLabel

Acute kidney injury during vancomycin therapy in critically ill children.

@en

Acute kidney injury during vancomycin therapy in critically ill children.

@nl

P1433

Q46698824-B6DEDBC4-2B3A-4ACB-88AB-BD529C120457

P1476

Q46698824-BB24E280-5073-4CC4-97D1-8FFEB8AA5BFA

P2093

Q46698824-174A2908-B1B8-4BB3-86C1-2F08E39BA31F

Q46698824-A2FF733D-170F-4B38-801E-EF0FCFCA25BC

Q46698824-BDF17700-E540-40DB-B9A8-4E5142381A76

Q46698824-CAA45D42-A5F0-4228-9FF5-10DE8E1439ED

Q46698824-CB8AA95A-BA0F-4A69-89CD-80A777307D28

P2860

Q46698824-03148A2A-694E-4D11-9435-AE6D02989D9A

Q46698824-0EF14058-67F9-4C25-8E5E-395EECD96329

Q46698824-12F61245-B252-42AC-8689-EAA9CCA13D0B

Q46698824-1C10DE8B-2AF1-43FD-9E07-954A4EBF96C8

Q46698824-1FB9AB82-B5A5-4135-B3DA-3651E990C76B

Q46698824-20DC5119-5C07-43E7-8CBD-0C3CB79E1938

Q46698824-277DCB3B-EE45-4AB9-9477-F24906AC7C35

Q46698824-2A867D9B-1B29-4AB6-8D33-7F5ADDFF04D6

Q46698824-392E789B-450D-45C1-AF55-AE2E8753202F

Q46698824-3EECC1BC-13E2-40C7-A397-4B6071144AF7

P304

Q46698824-1ADC8C23-8596-4BB9-9C3C-89415382EC63

P31

Q46698824-125ECEE2-4002-4F0B-824E-A27D14B3046F

P356

Q46698824-7278AAE7-82F4-4727-B95C-FC5A26FF33C0

P407

Q46698824-6D586FDC-EF6A-4AD1-8C3D-4AA2FA3180F8

P433

Q46698824-9CB6278B-EB9B-4051-9718-22EB11B6EBFF

P478

Q46698824-FF85D084-E68A-4716-90E8-B33DF7DEE369

P577

Q46698824-E88D98FF-DD42-49D4-AA88-0C6DB1980B00

P698

Q46698824-136D24D3-C86B-4763-923B-36A3CD3CCD1D

P356

P1433

Pharmacotherapy

P1476

Acute kidney injury during vancomycin therapy in critically ill children.

@en

P2093

Ana Paredes

http://www.w3.org/2001/XMLSchema#string

Andre Raszynski

http://www.w3.org/2001/XMLSchema#string

Balagangadhar R Totapally

http://www.w3.org/2001/XMLSchema#string

Helen Lee

http://www.w3.org/2001/XMLSchema#string

Jacqueline Machado

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats

Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

Modified RIFLE criteria in critically ill children with acute kidney injury.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

P304

598-602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1259

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23526674

http://www.w3.org/2001/XMLSchema#string